Evidence map›Paper›PMID 37175037›Full record

ArticleDiagnostics (Basel, Switzerland)2023

Comparative Study of the Myocardium of Patients from Four COVID-19 Waves.

Lubov Borisovna Mitrofanova, Igor Aleksandrovich Makarov, Andrey Nikolaevich Gorshkov, Andrey Leonidovich Runov, Maxim Sergeevich Vonsky, Maria Mikhailovna Pisareva, Andrey Borisovich Komissarov, Taiana Alekseevna Makarova, Qingli Li, Tatiana Leonidovna Karonova and 2 more

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. High Risk of Heart Tumors after COVID-19.Life (Basel, Switzerland) · 2023
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Lubov Borisovna MitrofanovaAlmazov National Medical Research Centre, St. Petersburg 197341, Russia.
Igor Aleksandrovich MakarovAlmazov National Medical Research Centre, St. Petersburg 197341, Russia.ORCID 0000-0001-6175-8403
Andrey Nikolaevich GorshkovAlmazov National Medical Research Centre, St. Petersburg 197341, Russia.
Andrey Leonidovich RunovAlmazov National Medical Research Centre, St. Petersburg 197341, Russia.
Maxim Sergeevich VonskyAlmazov National Medical Research Centre, St. Petersburg 197341, Russia.
Maria Mikhailovna PisarevaSmorodintsev Research Institute of Influenza, St. Petersburg 197376, Russia.
Andrey Borisovich KomissarovSmorodintsev Research Institute of Influenza, St. Petersburg 197376, Russia.
Taiana Alekseevna MakarovaAlmazov National Medical Research Centre, St. Petersburg 197341, Russia.
Qingli LiEast China Normal University, Shanghai 200241, China.
Tatiana Leonidovna KaronovaAlmazov National Medical Research Centre, St. Petersburg 197341, Russia.
Alexandra Olegovna KonradiAlmazov National Medical Research Centre, St. Petersburg 197341, Russia.ORCID 0000-0001-8169-7812
Evgeny Vladimirovich ShlaykhtoAlmazov National Medical Research Centre, St. Petersburg 197341, Russia.
Federal Almazov North-West Medical Research Centre · RUResearch Institute of Influenza · RUEast China Normal University · CN

Funding

This research was financially supported by the Ministry of Science and Higher Education of the Russian Federation 075-15-2022-301
6 · The paper itself

Abstract

backgroundFew studies have compared COVID-19 patients from different waves. This study aims to conduct a clinical and morphological analysis of patients who died from COVID-19 during four waves.

methodsThe study involved 276 patients who died from COVID-19 during four waves, including 77 patients in the first wave, 119 patients in the second wave, and 78 patients in the third wave. We performed a histological examination of myocardium samples from autopsies and additionally analyzed the samples by PCR. We conducted immunohistochemistry of the myocardium for 21 samples using antibodies against CD3, CD45, CD8, CD68, CD34, Ang1, VWF, VEGF, HLA-DR, MHC1, C1q, enteroviral VP1, and SARS-CoV-2 spike protein. We also did immunofluorescent staining of three myocardial specimens using VP1/SARS-CoV-2 antibody cocktails. Further, we ran RT-ddPCR analysis for 14 RNA samples extracted from paraffin-embedded myocardium. Electron microscopic studies of the myocardium were also performed for two samples from the fourth wave.

resultsAmong the 276 cases, active myocarditis was diagnosed in 5% (15/276). Of these cases, 86% of samples expressed VP1, and individual cells contained SARS-CoV-2 spike protein in 22%. Immunofluorescence confirmed the co-localization of VP1 and SARS-CoV-2 spike proteins. ddPCR did not confidently detect SARS-CoV-2 RNA in the myocardium in any myocarditis cases. However, the myocardium sample from wave IV detected a sub-threshold signal of SARS-CoV-2 by qPCR, but myocarditis in this patient was not confirmed. Electron microscopy showed several single particles similar to SARS-CoV-2 virions on the surface of the endothelium of myocardial vessels. A comparison of the cardiovascular complication incidence between three waves revealed that the incidence of hemorrhage (48 vs. 24 vs. 17%), myocardial necrosis (18 vs. 11 vs. 4%), blood clots in the intramural arteries (12 vs. 7 vs. 0%), and myocarditis (19 vs. 1 vs. 6%) decreased over time, and CD8-T-killers appeared. Immunohistochemistry confirmed the presence of endotheliitis in all 21 studied cases.

conclusionsThis study compared myocardial damage in patients who died during three COVID-19 waves and showed a decrease in the incidence of endotheliitis complications (thrombosis, hemorrhage, necrosis) and myocarditis over time. However, the connection between myocarditis and SARS-CoV-2 infection remains unproven.

Indexed as

COVID-19 wavesimmunofluorescent myocardial studyimmunohistochemicalmyocarditispolymerase chain reactionultrastructural myocardial study

Identifiers

PMID37175037
PMCPMC10178873
OpenAlexW4376630208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.